Fibrous tissues of the musculoskeletal system are plagued by their poor intrinsic healing capacity. In the previous funding cycle, we developed enabling technologies towards the production of a novel class of composite electrospun scaffolds, and used these scaffolds to develop cell-based tissue engineered constructs with native-like tissue properties and organization. In this competitive renewal, we shift our focus to using these enabling technologies to enhance endogenous tissue repair. Our focus is on the knee meniscus, a fibrous tissue critical for proper load transfer and for which current repair strategies do not restore function. The overall objective of this renewal is to use these scaffolds to deliver multiple agents over different temporal scales to specifically address the inherent limitations to endogenous meniscus repair. These limitations in the adult include synovial inflammation, low endogenous cellularity, and hindered cell mobility to the wound interface. This proposal will employ composite scaffolds (developed during the first funding cycle) that provide a stable fiber fraction (polycaprolactone (PCL), to provide an instructional pattern and mechanical stability), a sacrificial fiber fraction (polyethylene oxide (PEO), to define initial scaffold porosity), and an MMP-cleavable hyaluronic acid (HA) fiber fraction (that degrades in response to elevated proteolytic activity in synovial fluid of patients with meniscus damage). Degradation of the HA fiber fraction will both enhance cellular infiltration (by increasing scaffol porosity) and at the same time reduce degradation of nascent repair tissue (via competitive inhibition of synovial MMPs). These composite scaffolds will also address limited cellular mobility through the dense surrounding ECM by rapidly and locally decreasing nuclear stiffness (via the delivery of agents that reduce heterochromatin content and/or Lamin A/C processing) in endogenous meniscus cells. Finally, these scaffolds will selectively recruit endogenous meniscus cells towards the wound interface, to accelerate and sustain the repair process, via the delivery of stromal derived factor-1? (SDF-1?), a potent cytokine that increases meniscal cell migration. The synergistic interactions of these different repair adjuvants will be validated through in vitro scaffold and meniscal explant studies, and then tested in our large animal (ovine) meniscus defect model. If successful, these studies and technologies will set the stage for clinical translation and treatment of human meniscal injury by overcoming the inherent limitations to endogenous meniscus repair.

Public Health Relevance

This competitive renewal builds on our previous funding wherein we developed composite nanofibrous scaffolds to engineer dense connective tissues. In this proposal, we apply our unique multi-polymer scaffolds to orchestrate and advance endogenous meniscus repair. Meniscus injuries are plagued by a poor intrinsic healing capacity and current treatment options often fail, resulting in degeneration of the underlying cartilage. To address this, we design scaffolds to respond to the inflammatory environment to increase scaffold porosity and release agents to enable 3D cell migration and recruit cells to the wound interface. If successful, this approach will represent a novel step towards clinical translation an improved treatment of an increasingly prevalent condition. Moreover, this novel material technology and delivery strategy could be extended to treat other dense connective tissues that do not heal.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
2R01AR056624-06
Application #
8816382
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Wang, Fei
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Orthopedics
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Heo, Su-Jin; Driscoll, Tristan P; Thorpe, Stephen D et al. (2016) Differentiation alters stem cell nuclear architecture, mechanics, and mechano-sensitivity. Elife 5:
Heo, Su-Jin; Han, Woojin M; Szczesny, Spencer E et al. (2016) Mechanically Induced Chromatin Condensation Requires Cellular Contractility in Mesenchymal Stem Cells. Biophys J 111:864-74
Fisher, Matthew B; Henning, Elizabeth A; Söegaard, Nicole et al. (2015) Engineering meniscus structure and function via multi-layered mesenchymal stem cell-seeded nanofibrous scaffolds. J Biomech 48:1412-9
Driscoll, Tristan P; Cosgrove, Brian D; Heo, Su-Jin et al. (2015) Cytoskeletal to Nuclear Strain Transfer Regulates YAP Signaling in Mesenchymal Stem Cells. Biophys J 108:2783-93
Baker, Brendon M; Trappmann, Britta; Wang, William Y et al. (2015) Cell-mediated fibre recruitment drives extracellular matrix mechanosensing in engineered fibrillar microenvironments. Nat Mater 14:1262-8
Heo, Su-Jin; Thorpe, Stephen D; Driscoll, Tristan P et al. (2015) Biophysical Regulation of Chromatin Architecture Instills a Mechanical Memory in Mesenchymal Stem Cells. Sci Rep 5:16895
Tibbitt, Mark W; Rodell, Christopher B; Burdick, Jason A et al. (2015) Progress in material design for biomedical applications. Proc Natl Acad Sci U S A 112:14444-51
Wade, Ryan J; Bassin, Ethan J; Rodell, Christopher B et al. (2015) Protease-degradable electrospun fibrous hydrogels. Nat Commun 6:6639
Qu, Feini; Pintauro, Michael P; Haughan, Joanne E et al. (2015) Repair of dense connective tissues via biomaterial-mediated matrix reprogramming of the wound interface. Biomaterials 39:85-94
Wade, Ryan J; Bassin, Ethan J; Gramlich, William M et al. (2015) Nanofibrous hydrogels with spatially patterned biochemical signals to control cell behavior. Adv Mater 27:1356-62

Showing the most recent 10 out of 44 publications